Vecuronium bromide is compatible in solution with:
0.9% Sodium Chloride Injection
5% Dextrose Injection
Sterile water for injection
Dextrose 5% and Sodium Chloride Injection
Lactated Ringer’s Injection
Use within 24 hours of mixing with the above solutions.
When reconstituted with Bacteriostatic Water for Injection: CONTAINS BENZYL ALCOHOL, WHICH IS NOT INTENDED FOR USE IN NEWBORNS. Use within 5 days. May be stored at room temperature or refrigerated.
When reconstituted with sterile water for injection or other compatible I.V. solutions: Refrigerate vial. Use within 24 hours. Single use only. Discard unused portion.
Parenteral drug products should be inspected visually for particulate matter and discoloration prior to administration whenever solution and container permit.
Vecuronium Bromide for Injection is supplied as follows:
NDC Number Packaging Configuration Vial Size
10019-481-01 Vecuronium Bromide for Injection 10mL
(diluent not supplied)
Shelf pack carton of 10 individual vials.
Store dry powder at controlled room temperature 15°-30°C (59°-86°F).
PROTECT FROM LIGHT.
Product Nos.: 1053-10
Mfd. for Baxter Healthcare Corporation
Deerfield, IL 60015 USA
by: Steris Laboratories, Inc.
Phoenix, AZ 85043 USA
| VECURONIUM BROMIDE |
vecuronium bromide injection, powder, lyophilized, for solution
|Labeler — Watson Laboratories, Inc.|
Revised: 06/2007 Watson Laboratories, Inc.
DrugInserts.com provides trustworthy package insert and label information about marketed drugs as submitted by manufacturers to the US Food and Drug Administration. Package information is not reviewed or updated separately by DrugInserts.com. Every individual package label entry contains a unique identifier which can be used to secure further details directly from the US National Institutes of Health and/or the FDA.